Cerebrolysin: maikaʻi a pōʻino paha

ʻIke ʻia nā kaukani lāʻau hou ma ka honua i kēlā me kēia makahiki. Noho mau kekahi i ka "mākaʻi" i ke olakino kanaka, ʻo ka lua, me ka ʻole o ka hōʻoia ʻana i ko lākou pono a me ko lākou koʻikoʻi, pau ka hana ʻana, a ke hoʻomau nei ka hoʻohana ʻana i ke kolu, ʻoiai ʻo ka hopena therapeutic o kā lākou hoʻohana ʻana he hoʻopaʻapaʻa loa. ʻO ka hui hope o nā lāʻau lapaʻau e pili ana iā Cerebrolysin, ʻaʻole i hoʻokomo ʻia i loko o nā ʻōlelo aʻoaʻo WHO no ka mālama ʻana i kekahi maʻi, ʻaʻole i ʻae ʻia e ka FDA a me ka European Medicines Agency. Ma ʻAmelika Hui Pū ʻIa, Kanada, Pelekane Nui, Israel a me ka hapa nui o nā ʻāina ʻEulopa, ua pāpā ʻia ka hoʻohana ʻana a hiki ke hoʻopaʻi ʻia e ke kānāwai. ʻOiai ma Kina, Ukraine, Lūkia a me nā ʻāina CIS, hoʻohana mau ʻia ʻo Cerebrolysin no ka maʻi ischemic stroke, Alzheimer's a me dementia, traumatic brain injuries. Akā, e like me ka hōʻike ʻana o ka hoʻomaʻamaʻa, ʻoi aku ka liʻiliʻi o kēlā me kēia makahiki, no ka mea ʻaʻole i hōʻoia ʻia ka hopena o ka lāʻau lapaʻau.

He aha ka Cerebrolysin a he aha kona mau hōʻailona no ka hoʻohana ʻana

ʻO Cerebrolysin kahi hoʻomākaukau olaola i hana ʻia e ka hoʻomaʻemaʻe enzymatic o nā protein lolo puaʻa. Loaʻa iā 80% nā peptides kaumaha haʻahaʻa haʻahaʻa a me 20% mau waikawa amino manuahi. Hoʻokomo ka mea hana i ka pale koko-lolo, komo pololei i nā pūnana nerve. Wahi a nā ʻōlelo aʻo no ka lāʻau lapaʻau, he mau hana pharmacological ʻo Cerebrolysin:

  • hoʻonui i ka pono o ka metabolism aerobic o ka lolo, hoʻomaikaʻi i ka synthesis protein intracellular i ka wā ʻelemakule a me ka ulu ʻana o ka lolo;
  • he hopena maikaʻi ma nā kaʻina hana o ka hoʻomanaʻo ʻana i ke kūʻē i ka hana cognitive;
  • ka pale ʻana i nā neurons mai ka lactic acidosis, pale i ka hoʻokumu ʻana o nā radical manuahi, e hōʻemi ana i ka hopena neurotoxic o nā waikawa amino excitatory;
  • ka pale ʻana i ka make neuronal i ka wā hypoxia a me ischemia.

Manaʻo ka mea hana i ka hoʻohana ʻana i ka Cerebrolysin no ka mālama ʻana i ka maʻi o Alzheimer, dementia, ischemic stroke, retardation noʻonoʻo i nā keiki, nā maʻi e pili ana i ka hemahema o ke keiki, a me ka cerebrovascular mau loa. lawa ole.

No ke aha i kānalua ai ka hopena o ka lāʻau

ʻO kahi lāʻau lapaʻau, inā ʻaʻole mākou e kamaʻilio e pili ana i nā generics, hele lōʻihi loa ia: mai kahi mole i loko o kahi paipu hale hana i kahi lāʻau.. He mea nui kēlā me kēia pae, mai ka hoʻomohala ʻana a hiki i ka hoʻomaka ʻana o ka mākeke. No nā lāʻau lapaʻau mua ʻo Cerebrolysin, no laila, ma hope o kona hana ʻana, ua hana ʻia nā hoʻokolohua lapaʻau me ka ʻole o ka hemahema, i manaʻo ʻia e hōʻoia i ka pono o ka lāʻau. Ma lalo wale nō o kēia kūlana hiki ke hoʻopaʻa inoa i kahi huahana lāʻau.

Eia naʻe, ʻaʻole hōʻoia nā haʻawina hou i ka maikaʻi o ka lāʻau lapaʻau i nā maʻi a me nā kūlana o ke kino i kuhikuhi ʻia i nā kuhikuhi.

Wahi a ka Cochrane Library, ke kumu mana loa o ka ʻike ma ke kahua o ka lāʻau lapaʻau e pili ana i nā hōʻike, ʻehiku mau haʻawina e pili ana i nā hopena o ka hoʻokele Cerebrolysin i ka maʻi ischemic stroke. Ua komo lākou i nā maʻi 1601 mai nā halemai ma nā ʻāina ʻokoʻa he ʻumi. Ua noʻonoʻo ʻia ka hopena o ka lāʻau i nā lā mua ʻelua ma hope o ka hahau ʻana. I loko o ka paʻakikī, ua kuhikuhi pū ʻia nā mea maʻi i nā lāʻau lapaʻau e hoʻoheheʻe a pale i nā clots koko. Ua loaʻa i ka hui ʻelua ka placebo therapy. Ua mau nā haʻawina mai 28 a 90 mau lā.

ʻO ka hopena:

  • i loko o nā haʻawina ʻeono, ʻaʻohe hopena liʻiliʻi o ka hoʻohui ʻana o Cerebrolysin i ka hopena o ka make. mai hahau;
  • ma 4 mau haʻawina, ʻaʻole i hoʻololi maoli ka lāʻau lapaʻau i ka helu o nā mea maʻi me nā hopena koʻikoʻi maikaʻi ʻole - ke kīnā, ka make, ka noho lōʻihi o ka haukapila;
  • ʻekolu mau haʻawina i hōʻoia i kahi loli nui ʻole i ka helu o nā make.

ʻEhā mau haʻawina hou e pili ana i ka poʻe 1435 i hōʻike i nā mea maʻi i ka hui Cerebrolysin i ʻoi aku ka nui o nā hopena koʻikoʻi ma mua o nā kumuhana e lawe ana i kahi placebo.

Ua hana pū ʻia nā hoʻāʻo ma ka hui o nā maʻi me ka dementia vascular. ʻO ka nui o ka poʻe i komo i nā haʻawina ʻeono he 597. ʻAʻole maikaʻi nā hopena i loaʻa. Ke hoʻopaʻapaʻa nei nā mea kākau o ka hoʻokolokolo e hiki ke loaʻa ka hopena maikaʻi o ka lāʻau lapaʻau i kēlā mau maʻi i ʻoluʻolu a maʻalahi paha nā hōʻailona.

ʻOiai ka maikaʻi ʻole o Cerebrolysin, aia ka nūhou maikaʻi i kēia mau mea a pau. Ua hōʻoia ka meta-analysis i ka palekana o ka hoʻohana ʻana i ka lāʻau lapaʻau no ʻekolu mau makahiki me nā hopena ʻaoʻao pōkole e like me ka pohō kaumaha, dizziness, headache, agitation, hopohopo a me ka manaʻo o ka wela me ka ʻole o ka hoʻololi ʻana i ka mahana o ke kino. Hiki i kēia ʻike ke hōʻoluʻolu i ka poʻe i kuhikuhi ʻia i kēia lāʻau e nā kauka.

I kēia manawa, ʻaʻole pāpā ʻia ka lāʻau lapaʻau ma Ukraine, Russia a me nā ʻāina CIS, akā hāʻawi ʻia i kona kumukūʻai kiʻekiʻe a me ka haʻahaʻa haʻahaʻa, ʻoi aku ka kiʻekiʻe o ka manaʻolana no ka nalowale ʻana o Cerebrolysin mai ka mākeke lāʻau.

Puna
  1. Wikipedia. – Cerebrolysin.
  2. Portal “Nānā”. - Pehea e hoʻomākaukau ai a paʻa i nā ʻāina like ʻole, akā aia ma Ukraine.
  3. NeuroNews Journal: Psychoneurology a me Neuropsychiatry. - ʻO Cerebrolysin i ka mālama ʻana i ka dementia vascular.
  4. Vidal Medicines Handbook. - Cerebrolysin® (Cerebrolysin®) kuhikuhi no ka hoʻohana. ​​​​
  5. Pūnaewele Pūnaewele ʻo Cochrane. – ʻO Cerebrolysin i ka hahau ʻana ischemic acute.
  6. ʻIkepili a me ka puka lawelawe "Indicator". - Pehea lākou e hana ai iā mākou: Cerebrolysin. Ma hea lākou i waiho ai i ka puaʻa?
  7. ʻO Alzheimer's Drug Discovery Foundation. – Cerebrolysin.